Study of 0.4% povidone-iodine nasal spray for SARS-CoV-2
Evaluatig the virucidal efficacy of 0.4% povidone-iodine nasal spray against SARS-CoV-2 in the patients’ nasopharynx at 3 minutes, 4 hours after PVP-I exposure.
Stay updated with breaking news from Precision System Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Evaluatig the virucidal efficacy of 0.4% povidone-iodine nasal spray against SARS-CoV-2 in the patients’ nasopharynx at 3 minutes, 4 hours after PVP-I exposure.
Magnetic Bead-based Nucleic Acid Market Key Trends and Analysis up to 2030
Magnetic Bead-based Nucleic Acid Market Key Trends and Analysis up to 2030
Investors are snapping up shares of companies that could benefit from the race to quell the disease. Read more at straitstimes.com.
As health authorities all over the globe search for ways to stop the monkeypox outbreak, investors are snapping up shares of companies that could benefit